The Role of Omega-3/Omega-6 Ratio on Appetite in Pulmonary Multidrug-Resistant Tuberculosis Patients
Downloads
Introduction: Tumour necrosis factor-alpha (TNF-α) levels, pro-inflammatory cytokines that suppress appetite, were discovered to be much higher in multidrug-resistant tuberculosis (MDR-TB) than in drug-sensitive TB. Research on the omega-3/omega-6 (êž·-3/êž·-6) polyunsaturated fatty acids (PUFAs) intake, which can support appetite in patients with MDR-TB, has never been performed. This study aimed to examine the relationship between êž·-3/êž·-6 PUFAs intake ratio and appetite mediated by TNF-α in pulmonary MDR-TB patients.
Methods: This was a cross-sectional study conducted on 46 male and female adults with MDR-TB undergoing intensive phase therapy. Data were collected through questionnaires, 1x24 hours food recall, anthropometric measurements, 100 mm visual analogue appetite scale, and venous blood collection.
Results: Correlation analysis used the Pearson and Spearman tests. The findings revealed the ratio of êž·-3/êž·-6 PUFAs intake of 0.11 ± 0.05, the median value of TNF-α 7.49(1.66-447.62) pg/mL, and an average appetite of 58.72 ± 26.7. There was no relationship between êž·-3/êž·-6 PUFAs intake ratio and TNF-α (r = 0.016; p = 0.91), likewise between êž·-3/êž·-6 PUFAs intake ratio with appetite (r = -0.1; p = 0.54), but there was a relationship between TNF-α and appetite (r = 0.031; p = 0.04).
Conclusion: There was no relationship between êž·-3/êž·-6 PUFAs intake ratio and TNF-α and appetite in pulmonary MDR-TB patients. However, there was a relationship between TNF-α and appetite. This study is the first to determine the correlation between êž·-3/êž·-6 PUFAs intake ratio and appetite in pulmonary MDR-TB patients.
(WHO) WHO. Global Tuberculosis Report 2018. Geneva, https://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-eng.pdf?sequence=1&isAllowed=y (2018).
Weng T, Sun F, Li Y, et al. Refining MDR-TB Treatment Regimens for Ultra Short Therapy (TB-TRUST): Study Protocol for a Randomized Controlled Trial. BMC Infect Dis 2021; 21: 183. [Journal]
Soeroto AY, Pratiwi C, Santoso P, et al. Factors Affecting Outcome of Longer Regimen Multidrug-Resistant Tuberculosis Treatment in West Java Indonesia: A Retrospective Cohort Study. PLoS One 2021; 16: e0246284. [PubMed]
Grobler L, Nagpal S, Sudarsanam TD, et al. Nutritional Supplements for People being Treated for Active Tuberculosis. Cochrane Database Syst Rev 2016; 2016: CD006086. [PubMed]
Moraes ML de, Ramalho DM de P, Delogo KN, et al. Association between Serum Selenium Level and Conversion of Bacteriological Tests during Antituberculosis Treatment. J Bras Pneumol 2014; 40: 269–278. [PubMed]
Zhang M-W, Zhou L, Zhang Y, et al. Treatment Outcomes of Patients with Multidrug and Extensively Drug-Resistant Tuberculosis in Zhejiang, China. Eur J Med Res 2021; 26: 31. [PubMed]
Song T, Li L-J, Liu J-L, et al. Study on the Relationship between Changes of Immune Cells and TNF-α in Peripheral Blood of Patients with Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis. Eur Rev Med Pharmacol Sci 2018; 22: 1061–1065. [PubMed]
Basingnaa A, Antwi-Baffour S, Nkansah DO, et al. Plasma Levels of Cytokines (IL-10, IFN-γ and TNF-α) in Multidrug Resistant Tuberculosis and Drug Responsive Tuberculosis Patients in Ghana. Dis (Basel, Switzerland); 7. Epub ahead of print December 2018. [PubMed]
Hariyanto TI, Kurniawan A. Appetite Problem in Cancer Patients: Pathophysiology, Diagnosis, and Treatment. Cancer Treat Res Commun 2021; 27: 100336. [PubMed]
Pizzini A, Lunger L, Sonnweber T, et al. The Role of Omega-3 Fatty Acids in the Setting of Coronary Artery Disease and COPD: A Review. Nutrients; 10. Epub ahead of print December 2018. [PubMed]
Simopoulos AP. Genetic Variation, Diet, Inflammation, and the Risk for COVID-19. Lifestyle Genomics 2021; 14: 37–42. [PubMed]
van der Meij BS, Wijnhoven HAH, Lee JS, et al. Poor Appetite and Dietary Intake in Community-Dwelling Older Adults. J Am Geriatr Soc 2017; 65: 2190–2197. [PubMed]
Calder PC. Omega-3 Fatty Acids and Inflammatory Processes: From Molecules to Man. Biochem Soc Trans 2017; 45: 1105–1115. [PubMed]
Hu C, Yang M, Zhu X, et al. Effects of Omega-3 Fatty Acids on Markers of Inflammation in Patients with Chronic Kidney Disease: A Controversial Issue. Ther Apher Dial 2018; 22: 124–132. [PubMed]
Avila-Carrasco L, Pavone MA, González E, et al. Abnormalities in Glucose Metabolism, Appetite-Related Peptide Release, and Pro-inflammatory Cytokines Play a Central Role in Appetite Disorders in Peritoneal Dialysis. Front Physiol 2019; 10: 630. [PubMed]
Lidiyawati L, Kartini A. Hubungan Asupan Asam Lemak Jenuh, Asam Lemak Tidak Jenuh dan Natrium dengan Kejadian Hipertensi Pada Wanita Menopause di Kelurahan Bojongsalaman. J Nutr Coll; 3. Epub ahead of print 2014. [Journal]
Mattox TW. Cancer Cachexia: Cause, Diagnosis, and Treatment. Nutr Clin Pract 2017; 32: 599–606. [PubMed]
Simopoulos AP. An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity. Nutrients 2016; 8: 128. [PubMed]
Sedighiyan M, Abdollahi H, Karimi E, et al. Omega-3 Polyunsaturated Fatty Acids Supplementation Improve Clinical Symptoms in Patients with COVID-19: A Randomised Clinical Trial. Int J Clin Pract 2021; 75: e14854. [PubMed]
Park Y, Watkins BA. Dietary PUFAs and Exercise Dynamic Actions on Endocannabinoids in Brain: Consequences for Neural Plasticity and Neuroinflammation. Adv Nutr 2022; 13: 1989–2001. [PubMed]
Copyright (c) 2023 Fattrias Handayani Jayaatmaja, Nurul Ratna Mutu Manikam, Inge Permadhi, Neni Sawitri, Budi Rahayu, Adityo Wibowo, Fariz Nurwidya
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.